An illustrative example is the study by Zhou et al., in which tumor cell-derived exosomes were extracted and loaded with CCL22 siRNA (spMEXO), leading to the successful inhibition of DC/Treg interactions and Treg expression, subsequently impeding tumor growth and providing novel possibilities for cancer treatment [104]. This evidence concerns the gene CCL22 and neoplasm.